A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
- Posted on July 11, 2026
- By CNBC
- 0 Views
- 1 min read
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.